TrialPloS one2014

Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial.

Kristin Brekke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.